| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/27/2001 | US6194178 Method for the production of sialylated oligosaccharides |
| 02/27/2001 | US6194174 Histidine kinase, 636 HK, of staphylococcus aureus |
| 02/27/2001 | US6194172 Cytokine designated lerk-6 |
| 02/27/2001 | US6194171 Also vectors, transformed cells; useful for expression in cells for the purposes of identifying agonists or antagonists of ataxin-2-binding protein function |
| 02/27/2001 | US6194170 MurF of Streptococcus pneumoniae |
| 02/27/2001 | US6194159 Facile method for identifying regulated promoters |
| 02/27/2001 | US6194158 Diagnosing cancerous cell phenotype; monitor cells for transcription of nucleotide sequences, presence of transcripts are indicators of cancerous propagation |
| 02/27/2001 | US6194156 Isolated nucleic acid molecules which encode TAGE molecules, and uses thereof |
| 02/27/2001 | US6194154 Diagnosing cancerous transformation of human cells |
| 02/27/2001 | US6194153 Methods for determining risk of developing alzheimer's disease by detecting mutations in the presenilin 1 (PS-1) gene |
| 02/27/2001 | US6194152 Nucleotide sequences for the diagnosis and treatment of human urogenital cancers |
| 02/27/2001 | US6194151 Nucleotide sequences coding binding polypeptide; for the detection of modulators of tumor necrosis factor activity; for the treatment of cell proliferation and differentiation defects |
| 02/27/2001 | US6194149 Target-dependent reactions using structure-bridging oligonucleotides |
| 02/27/2001 | US6194148 Method for detecting a hybridized nucleic acid molecule |
| 02/27/2001 | US6194147 Classification of human leukocyte antigens; amplifying human leukocyte antigen sequences, hybridizing probes and detecting nucleotide sequence hybrids, detecting impurities, calibrating products with control alleles |
| 02/27/2001 | US6194146 Situ and in vitro hybridization method and buffer |
| 02/27/2001 | US6194145 Amplifying microorganism nucleotide sequences; hybridizing two preferential primers to nucleotide sequences, expanding primers, separating expansion products and miroorganism nucleotide sequences, duplicate the process |
| 02/27/2001 | US6194144 Generating two terminated nucleic acids; determination molecular weight; calibration |
| 02/27/2001 | US6194143 Substrates for human cytomegalovirus protease |
| 02/27/2001 | US6194142 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2, and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses |
| 02/27/2001 | US6194141 Detecting modulator of viral propagation; incubate viral nucleotide sequence mixture with metals, incubate second mixture with modulator, calibrate and compare amount of uridine incorporated into transcripts in both mixtures |
| 02/27/2001 | US6193981 Methods and compositions for impairing multiplication of HIV-1 |
| 02/27/2001 | US6193965 Administering therapeutically effective amount of reagent which modulates kinase activity for treating cell proliferative disorder associated with c-jun n-terminal kinase disorder, |
| 02/27/2001 | US6193873 Sample detection to initiate timing of an electrochemical assay |
| 02/27/2001 | US6193866 Separation of charged particles by a spatially and temporally varying electric field |
| 02/27/2001 | CA2156743C In-situ hybridization method using reca protein and reca protein having marker or ligand for use in said method |
| 02/27/2001 | CA1341191C Detection of neu gene expression and products |
| 02/26/2001 | CA2281010A1 Diagnostic method |
| 02/22/2001 | WO2001013268A2 Specific identifiers of amino-acid and base sequences |
| 02/22/2001 | WO2001013126A1 Microelectronic molecular descriptor array devices, methods, procedures, and formats for combinatorial selection of intermolecular ligand binding structures and for drug screening |
| 02/22/2001 | WO2001013124A1 Method for controlling the quality of the endothelium lining of blood vessels prostheses |
| 02/22/2001 | WO2001013120A1 Microparticles with multiple fluorescent signals and methods of using same |
| 02/22/2001 | WO2001013118A2 Methods and compositions for diagnosis of hepatoma |
| 02/22/2001 | WO2001013117A2 Proteins, genes and their use for diagnosis and treatment of breast cancer |
| 02/22/2001 | WO2001013115A2 Method and device for identifying a biopolymer sequence on a solid surface |
| 02/22/2001 | WO2001013108A1 Method for identifying modulating compounds of neurotransmitters |
| 02/22/2001 | WO2001013103A1 Analytical apparatus and method |
| 02/22/2001 | WO2001013102A1 Sensor devices and analytical methods for their use |
| 02/22/2001 | WO2001013096A1 Device and method for determining multiple analytes |
| 02/22/2001 | WO2001013088A1 Methods and apparatuses for stretching polymers |
| 02/22/2001 | WO2001013086A2 Detection of nucleic acids |
| 02/22/2001 | WO2001012862A2 Compositions and methods for preparing oligonucleotide solutions |
| 02/22/2001 | WO2001012861A1 Gene cloning |
| 02/22/2001 | WO2001012859A2 Detection of differences in nucleic acids by inhibition of spontaneous dna branch migration |
| 02/22/2001 | WO2001012858A1 PPARδ LINKS APC TO CHEMOPREVENTIVE DRUGS |
| 02/22/2001 | WO2001012857A2 Methods of surveying for cc (beta) chemokine receptor variants and their association with hiv-1 transmission and/or disease progression |
| 02/22/2001 | WO2001012856A2 Analysis of sequence tags with hairpin primers |
| 02/22/2001 | WO2001012855A2 Binary encoded sequence tags |
| 02/22/2001 | WO2001012854A2 Color compensation for temperature and electronic gains |
| 02/22/2001 | WO2001012853A1 Method for identification of the indicators of contamination in samples |
| 02/22/2001 | WO2001012852A2 Polymerase extension at 3' terminus of pna-dna chimera |
| 02/22/2001 | WO2001012851A2 Identification of genetic markers of biological age and metabolism |
| 02/22/2001 | WO2001012850A1 Non-sporulating basidomycetes |
| 02/22/2001 | WO2001012849A1 Method of distinguishing nucleic acids and kits for nucleic acid test |
| 02/22/2001 | WO2001012848A2 Genetic marker for rheumatoid arthritis |
| 02/22/2001 | WO2001012847A2 Isolation of cells from forensic samples for dna-typing |
| 02/22/2001 | WO2001012846A1 Preparation of metal oxide supports loaded with biomolecules |
| 02/22/2001 | WO2001012845A1 Screening for udp-glucose: glycoprotein glucosyltransferase (uggt) activity |
| 02/22/2001 | WO2001012844A1 Rapid method for measuring complex carbohydrates in mammalian tissue |
| 02/22/2001 | WO2001012843A2 Hydrogen peroxide monitoring |
| 02/22/2001 | WO2001012842A1 Methods and targets of antibiotic resistance |
| 02/22/2001 | WO2001012841A1 Assistance method for interpretation of bacteria sensitivity tests to antibiotics |
| 02/22/2001 | WO2001012840A2 Anti-epha2 antibodies as a cancer diagnostic |
| 02/22/2001 | WO2001012839A1 Method for detecting, treating, and monitoring conditions associated with activation of the coagulation response |
| 02/22/2001 | WO2001012823A2 Macular degeneration diagnostics and therapeutics |
| 02/22/2001 | WO2001012819A2 Protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 02/22/2001 | WO2001012818A1 Neutral cerebral-sphingomyelinase |
| 02/22/2001 | WO2001012817A1 Evolution and use of enzymes for combinathorial and medicinal chemistry |
| 02/22/2001 | WO2001012811A1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 02/22/2001 | WO2001012806A2 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 02/22/2001 | WO2001012805A1 Methods for diagnosis and treatment of human diseases including hypertension |
| 02/22/2001 | WO2001012798A2 Male sterile plants |
| 02/22/2001 | WO2001012796A2 Pkd constructs and screening methods |
| 02/22/2001 | WO2001012790A2 Isomerase proteins |
| 02/22/2001 | WO2001012786A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | WO2001012785A1 Ex vivo generation of functional osteoclasts from bone marrow in a three-dimensional bioreactor |
| 02/22/2001 | WO2001012781A1 13 human colon and colon cancer associated proteins |
| 02/22/2001 | WO2001012778A2 Flocculation of cell material |
| 02/22/2001 | WO2001012777A2 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
| 02/22/2001 | WO2001012776A2 18 human secreted proteins |
| 02/22/2001 | WO2001012775A2 25 human secreted proteins |
| 02/22/2001 | WO2001012699A1 Electrically conductive polymers capable of being covalently grafted on by light, method for obtaining same and uses as supports in probes for specific identification in electronic biosensors |
| 02/22/2001 | WO2001012673A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 02/22/2001 | WO2001012672A2 Cytokine receptor common gamma chain like |
| 02/22/2001 | WO2001012671A1 Human tumor necrosis factor receptor tr16 |
| 02/22/2001 | WO2001012670A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | WO2001012664A2 Notch receptor ligands and uses thereof |
| 02/22/2001 | WO2001012663A2 Hematopoietic regulatory factors and methods of use thereof |
| 02/22/2001 | WO2001012662A2 Membrane associated proteins |
| 02/22/2001 | WO2001012648A1 Novel transcription factor, bp1 |
| 02/22/2001 | WO2001012647A1 Gene expression modulated in ataxia telangiectasia tumorgenesis |
| 02/22/2001 | WO2001012598A2 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 02/22/2001 | WO2001012237A1 Support materials and imaging method for intraoral diagnostic purposes |
| 02/22/2001 | WO2001012182A1 Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor |
| 02/22/2001 | WO2001012142A1 Methods for assaying transglycosylase reactions, and for identifying inhibitors thereof |
| 02/22/2001 | WO2001011953A1 A large animal model of invasive pulmonary aspergillosis in an immunocompromised host |
| 02/22/2001 | WO2001011951A1 Mouse having human cytochrome p450 transferred therein |
| 02/22/2001 | WO2000078941A3 Methods and products for manipulating uncoupling protein expression |
| 02/22/2001 | WO2000078788B1 NOVEL cDNA ASSOCIATED WITH RENAL DISEASE |
| 02/22/2001 | WO2000077246A3 A METHOD FOR IDENTIFYING A DRUG CANDIDATE HAVING AN INHIBITORY ACTION ON FVII-TF ACTIVITY, AND FVIIa/TF ACTIVITY INHIBITING COMPOUNDS |